The problem doesn't lie with upper management but Supernus' out dated business model. These tactics to gain formulary status worked in the 90s but bankrupt companies today. New Molecules is all we should be busting our nut on moving forward. Spoiler alert there is nothing new about 812.
Would be a valid argument if we hadn’t bought Biscane for their new molecule in epilepsy...glad you thought of that before leadership.
Maybe quit trying to play CEO and focus on your responsibilities as a Sales Rep to educate physicians on the benefits of the products you DO have. This sounds harsh. I honestly don’t mean it that way, but it’s reality. How many self help books are out there about focusing on what you can control?
Would be a valid argument if we hadn’t bought Biscane for their new molecule in epilepsy...glad you thought of that before leadership.
Maybe quit trying to play CEO and focus on your responsibilities as a Sales Rep to educate physicians on the benefits of the products you DO have. This sounds harsh. I honestly don’t mean it that way, but it’s reality. How many self help books are out there about focusing on what you can control?
Huperzine A which is the active ingredient in Biscaynes product can be bought OTC off Amazon. That is NOT a new molecule.
I like it here. The job is easy, flexible, I’ve made a lot of money and some good friends. My stock options are worthless until the stock goes up another $13 or $14 but the bonus checks keep rollin in! I’m not being negative nor am I going to bury my head in the sand like the person who believes that ‘Supernus will take care of us’ or ‘there’s no world where Supernus discounts it’s culture for any amount of money’. Supernus stock has gone from a high of around $60 to $26. IMO something is wrong. Why? Perhaps it is the less than stellar future that market analysts see in our ADHD pipeline. It may be Trokendi XR was promoted as a weight loss drug to providers for 6 years and then thousands of these high growth targets were removed earlier in 2019. Another factor may be that Supernus has been paying the full retail cost of Trokendi XR for tens of thousands of patients with the Gold Card in an effort to inflate the number of Rx’s that are reported. One of the problems could even be that the sales team was paid a lot of money in bonus for prescriptions that the company itself paid for. What is the solution? Since this is my company, not just one that I work for, it may be in the company’s best interest to find some new sales leaders who are able to recognize that the position the company is in now may be a little deeper than ‘this is just part of the business cycle’.
$60 to $26 the cat’s out of the bag. The street finally discovered we are far from the next Shire.
Then bail. Like what someone else said about our R&D, we are what we are. Find greener grass if that’s what you want. But some of us believe in seeing this thing out and building long lasting healthy company. The only real complaint or criticism is that we were oversold the timeline of adhd. However, I do not believe we are being oversold on the potential that pipeline has for us.
The sad thing is the negative posters on here probably aren’t doing too well. And they probably aren’t doing too well because of their negativity. It’s a vicious cycle. Would be interesting to see what would happen if they focused more on the opportunity in front of them versus the inequity they perceive. Sorry, I been listening to a Dr. Phill podcast.
What were you saying about greener pasture? Just listened to Taylor’s vm and I am STOKED about our future. *eye roll*Then bail. Like what someone else said about our R&D, we are what we are. Find greener grass if that’s what you want. But some of us believe in seeing this thing out and building long lasting healthy company. The only real complaint or criticism is that we were oversold the timeline of adhd. However, I do not believe we are being oversold on the potential that pipeline has for us.
The sad thing is the negative posters on here probably aren’t doing too well. And they probably aren’t doing too well because of their negativity. It’s a vicious cycle. Would be interesting to see what would happen if they focused more on the opportunity in front of them versus the inequity they perceive. Sorry, I been listening to a Dr. Phill podcast.
Rockville please be diligent in setting a accurate forecast for 2020. Rockville please be diligent to factor in market changes that could impact bonus payout to prescription goal attainment for 2020.
YOU are who I thought you were!! This level of disconnect from reality by Rockville has reached an all time high. It's hurting shareholders and sales representatives. Thanks for this news right before Christmas!!!!
I better not see one corporate head try to defend their position on here. This was WRONG!
Rockville please be diligent in setting a accurate forecast for 2020. Rockville please be diligent to factor in market changes that could impact bonus payout to prescription goal attainment for 2020.
YOU are who I thought you were!! This level of disconnect from reality by Rockville has reached an all time high. It's hurting shareholders and sales representatives. Thanks for this news right before Christmas!!!!
I better not see one corporate head try to defend their position on here. This was WRONG!
Rockville please be diligent in setting a accurate forecast for 2020. Rockville please be diligent to factor in market changes that could impact bonus payout to prescription goal attainment for 2020.
YOU are who I thought you were!! This level of disconnect from reality by Rockville has reached an all time high. It's hurting shareholders and sales representatives. Thanks for this news right before Christmas!!!!
I better not see one corporate head try to defend their position on here. This was WRONG!
OR we could try calling on the drs that WRITE or have a reason to write the product, but remember they took those from us in Q2. I know from my interviews with other companies as of late that other companies pay their reps on ALL scripts, not just this BS called on universe crap. Nice smokescreen @$$hats. We’re onto your lies nowThe next announcement may be that Supernus has too many sales representatives. That would be another great way for Taylor to cut costs for this mess that he should take some credit for. Sales representatives should not be calling on multiple doctors that write 1 topiramate prescription per week.
Don’t count on a severance worth anything. Someone on here already laughed at industry standard. You’ll be lucky to get a week per year. So for the reps that have been here from the beginning, being loyal so you can “build” something is not even going to get you 2 months of pay.The next announcement may be that Supernus has too many sales representatives. That would be another great way for Taylor to cut costs for this mess that he should take some credit for. Sales representatives should not be calling on multiple doctors that write 1 topiramate prescription per week.
I have a feeling that will be remedied soon when most of the sales force finds new jobs.The next announcement may be that Supernus has too many sales representatives. That would be another great way for Taylor to cut costs for this mess that he should take some credit for. Sales representatives should not be calling on multiple doctors that write 1 topiramate prescription per week.
Then bail. Like what someone else said about our R&D, we are what we are. Find greener grass if that’s what you want. But some of us believe in seeing this thing out and building long lasting healthy company. The only real complaint or criticism is that we were oversold the timeline of adhd. However, I do not believe we are being oversold on the potential that pipeline has for us.
The sad thing is the negative posters on here probably aren’t doing too well. And they probably aren’t doing too well because of their negativity. It’s a vicious cycle. Would be interesting to see what would happen if they focused more on the opportunity in front of them versus the inequity they perceive. Sorry, I been listening to a Dr. Phill podcast.
Then bail. Like what someone else said about our R&D, we are what we are. Find greener grass if that’s what you want. But some of us believe in seeing this thing out and building long lasting healthy company. The only real complaint or criticism is that we were oversold the timeline of adhd. However, I do not believe we are being oversold on the potential that pipeline has for us.
The sad thing is the negative posters on here probably aren’t doing too well. And they probably aren’t doing too well because of their negativity. It’s a vicious cycle. Would be interesting to see what would happen if they focused more on the opportunity in front of them versus the inequity they perceive. Sorry, I been listening to a Dr. Phill podcast.
